Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
nuclear receptor subfamily 2 group E member 3 | 0.603 | 0.500 |
|
disease | 1.000 | None | 0.974 | 15 | 5 | 2000 | 2019 | |||||||||
|
nuclear receptor subfamily 2 group E member 3 | 0.603 | 0.500 |
|
disease | 0.700 | limited | 1.000 | 16 | 6 | 2000 | 2016 | |||||||||
|
nuclear receptor subfamily 2 group E member 3 | 0.603 | 0.500 |
|
disease | 0.650 | None | 1.000 | 15 | 1 | 2000 | 2017 | |||||||||
|
nuclear receptor subfamily 2 group E member 3 | 0.603 | 0.500 |
|
disease | 0.480 | strong | 1.000 | 1 | 6 | 2007 | 2019 | |||||||||
|
nuclear receptor subfamily 2 group E member 3 | 0.603 | 0.500 |
|
disease | 0.130 | None | 1.000 | 0 | 0 | 2009 | 2019 | |||||||||
|
nuclear receptor subfamily 2 group E member 3 | 0.603 | 0.500 |
|
phenotype | 0.110 | None | 1.000 | 0 | 0 | 2018 | 2018 | |||||||||
|
nuclear receptor subfamily 2 group E member 3 | 0.603 | 0.500 |
|
group | 0.110 | None | 1.000 | 0 | 3 | 2019 | 2019 | |||||||||
|
nuclear receptor subfamily 2 group E member 3 | 0.603 | 0.500 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2015 | 2015 | |||||||||
|
nuclear receptor subfamily 2 group E member 3 | 0.603 | 0.500 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2015 | 2015 | |||||||||
|
nuclear receptor subfamily 2 group E member 3 | 0.603 | 0.500 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | |||||||||
|
nuclear receptor subfamily 2 group E member 3 | 0.603 | 0.500 |
|
phenotype | 0.100 | None | 0 | 0 | ||||||||||||
|
nuclear receptor subfamily 2 group E member 3 | 0.603 | 0.500 |
|
phenotype | 0.100 | None | 0 | 0 | ||||||||||||
|
nuclear receptor subfamily 2 group E member 3 | 0.603 | 0.500 |
|
phenotype | 0.100 | None | 0 | 0 | ||||||||||||
|
nuclear receptor subfamily 2 group E member 3 | 0.603 | 0.500 |
|
disease | 0.100 | None | 0 | 0 | ||||||||||||
|
nuclear receptor subfamily 2 group E member 3 | 0.603 | 0.500 |
|
disease | 0.100 | None | 0 | 1 | ||||||||||||
|
nuclear receptor subfamily 2 group E member 3 | 0.603 | 0.500 |
|
phenotype | 0.100 | None | 0 | 0 | ||||||||||||
|
nuclear receptor subfamily 2 group E member 3 | 0.603 | 0.500 |
|
phenotype | 0.100 | None | 0 | 0 | ||||||||||||
|
nuclear receptor subfamily 2 group E member 3 | 0.603 | 0.500 |
|
disease | 0.100 | None | 0 | 0 | ||||||||||||
|
nuclear receptor subfamily 2 group E member 3 | 0.603 | 0.500 |
|
phenotype | 0.100 | None | 0 | 1 | ||||||||||||
|
nuclear receptor subfamily 2 group E member 3 | 0.603 | 0.500 |
|
disease | 0.100 | None | 0 | 2 | ||||||||||||
|
nuclear receptor subfamily 2 group E member 3 | 0.603 | 0.500 |
|
phenotype | 0.100 | None | 0 | 0 | ||||||||||||
|
nuclear receptor subfamily 2 group E member 3 | 0.603 | 0.500 |
|
phenotype | 0.100 | None | 0 | 0 | ||||||||||||
|
nuclear receptor subfamily 2 group E member 3 | 0.603 | 0.500 |
|
phenotype | 0.100 | None | 0 | 0 | ||||||||||||
|
nuclear receptor subfamily 2 group E member 3 | 0.603 | 0.500 |
|
group | 0.100 | None | 0 | 0 | ||||||||||||
|
nuclear receptor subfamily 2 group E member 3 | 0.603 | 0.500 |
|
phenotype | 0.100 | None | 0 | 0 |